NASDAQ:CHGA Avalon GloboCare (CHGA) Stock Price, News & Analysis $2.07 +0.03 (+1.47%) As of 09/18/2026 04:00 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsNews and TrendsSEC Filings About Avalon GloboCare Stock (NASDAQ:CHGA) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Avalon GloboCare alerts:Sign Up Key Stats Today's Range$2.00▼$2.1650-Day Range$1.86▼$6.1652-Week Range$1.79▼$55.40Volume54,659 shsAverage Volume420,546 shsMarket Capitalization$2.32 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview Avalon GloboCare Corp. is a life sciences company focused on developing cell-based technologies and precision medicine applications. Its work has included regenerative medicine, cancer diagnostics, and therapeutic platforms designed to support the development of personalized healthcare treatments. The company has also pursued technologies involving cellular processing, biomanufacturing, and related laboratory services. Avalon GloboCare’s activities have included collaborations and development programs intended to translate emerging cell and molecular science into clinical and commercial applications. Avalon GloboCare was established in the mid-2010s and has been headquartered in Freehold, New Jersey. Public company materials have identified David Jin as a senior executive and have described the company as serving the biotechnology and healthcare markets, although specific programs, operations, and leadership arrangements may change over time.AI Generated. May Contain Errors. Read More Avalon GloboCare Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks7th Percentile Overall ScoreCHGA MarketRank™: Avalon GloboCare scored higher than 7% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.7 / 5Analyst RatingSell Consensus RatingAvalon GloboCare has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoverageAvalon GloboCare has only been the subject of 1 research reports in the past 90 days.Read more about Avalon GloboCare's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Avalon GloboCare is -0.15, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Avalon GloboCare is -0.15, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted9.57% of the float of Avalon GloboCare has been sold short.Short Interest Ratio / Days to CoverAvalon GloboCare has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Avalon GloboCare has recently decreased by 69.67%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldAvalon GloboCare does not currently pay a dividend.Dividend GrowthAvalon GloboCare does not have a long track record of dividend growth. News and Social Media0.6 / 5News SentimentN/A News Coverage This WeekMarketBeat has tracked 1 news article for Avalon GloboCare this week, compared to 2 articles on an average week.Search InterestOnly 1 people have searched for CHGA on MarketBeat in the last 30 days. This is a decrease of -83% compared to the previous 30 days.MarketBeat Follows2 people have added Avalon GloboCare to their MarketBeat watchlist in the last 30 days. Company Ownership0.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Avalon GloboCare insiders have not sold or bought any company stock.Percentage Held by Insiders24.19% of the stock of Avalon GloboCare is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions1.42% of the stock of Avalon GloboCare is held by institutions.Read more about Avalon GloboCare's insider trading history. Receive CHGA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Avalon GloboCare and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CHGA Stock News HeadlinesChange Agents Regains Compliance with Nasdaq's Minimum Bid Price RequirementSeptember 17 at 9:00 AM | globenewswire.comDer aktuelle Kurs der Change Agents Corp Aktie beträgt 2,8900.September 1, 2026 | de.investing.comBezos… DOOMEDA single FCC filing hints Elon Musk is planning his biggest project yet - bigger than Tesla, SpaceX, and X combined - aimed at the $25 trillion AI industry. James Altucher says the plan could cut Amazon out of the AI race and disrupt Blue Origin, with a key deadline landing September 25.September 20 at 1:00 AM | Paradigm Press (Ad)Change Agents Completes Phase 2 of its Catch-Up Agentic AI Video Studio Platform; Development led by Caylent with Funding from Amazon Web Services GrantAugust 31, 2026 | globenewswire.comChange Agents Accepted into Seagate Partner Program, Expanding Access to AI Infrastructure EcosystemAugust 28, 2026 | globenewswire.comChange Agents Announces 1-for-20 Reverse Stock SplitAugust 27, 2026 | globenewswire.comChange Agents Corp. to Begin Trading on Nasdaq as CHGA Following Rebrand and AI Software TransformationJuly 21, 2026 | quiverquant.comQAvalon GloboCare Announces Strategic Transformation into Agentic AI Software Company; Rebrands as Change Agents Corp.July 21, 2026 | globenewswire.comSee More Headlines CHGA Stock Analysis - Frequently Asked Questions How have CHGA shares performed this year? Avalon GloboCare's stock was trading at $24.00 at the beginning of 2026. Since then, CHGA shares have decreased by 91.4% and is now trading at $2.07. How were Avalon GloboCare's earnings last quarter? Avalon GloboCare Corp. (NASDAQ:CHGA) posted its earnings results on Friday, August, 14th. The company reported ($2.80) earnings per share (EPS) for the quarter. When did Avalon GloboCare's stock split? Avalon GloboCare shares reverse split on the morning of Monday, October 28th 2024.The 1-15 reverse split was announced on Thursday, October 24th 2024. The number of shares owned by shareholders was adjusted after the market closes on Friday, October 25th 2024. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split. How do I buy shares of Avalon GloboCare? Shares of CHGA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Avalon GloboCare own? Based on aggregate information from My MarketBeat watchlists, some other companies that Avalon GloboCare investors own include Sangamo Therapeutics (SGMO), Ford Motor (F), Pfizer (PFE), Plug Power (PLUG), NVIDIA (NVDA), Intel (INTC). Company Calendar Last Earnings8/14/2026Today9/20/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (6m+) 1-Year History Sep 25 Dec 25 Mar 26 Jun 26 Sep 26 CHGA's financial health is in the Yellow zone, according to TradeSmith. CHGA has been in this zone for over 6 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorTechnology Industry Software Sub-IndustryApplication Software Current SymbolNASDAQ:CHGA Previous SymbolNASDAQ:ALBT CIK1630212 Webwww.avalon-globocare.com Phone(732) 780-4400Fax732-780-5600Employees5Year Founded2014Profitability EPS (Trailing Twelve Months)($13.80) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$18.26 million Net MarginsN/A Pretax Margin-5,608.29% Return on EquityN/A Return on Assets-53.69% Debt Debt-to-Equity RatioN/A Current Ratio0.11 Quick Ratio0.11 Sales & Book Value Annual Sales$1.26 million Price / Sales1.84 Cash FlowN/A Price / Cash FlowN/A Book Value($75.46) per share Price / Book-0.03Miscellaneous Outstanding Shares1,120,000Free Float849,000Market Cap$2.32 million OptionableNot Optionable Beta-0.05 Social Links (Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.Get This Free Report This page (NASDAQ:CHGA) was last updated on 9/20/2026 by MarketBeat.com Staff. From Our Partners$40,000,000,000,000The national debt just hit 40 trillion dollars, and the U.S. now spends more on interest payments than on its ...American Alternative | SponsoredNo Wallstreet. No Advisor. No Problem.Savings accounts pay just 0.58 percent interest. Andy Howard, co-founder of Meridian Capital, says liquidity p...Awesomely | SponsoredA “bloodbath” Is ComingReports suggest some Silicon Valley billionaires are stockpiling gold, guns, and gas masks - or leaving the co...TradeSmith | SponsoredBefore Anthropic becomes impossible to ignore...Riot Platforms just struck a 20-year, 191-megawatt data-center agreement tied to Anthropic, reportedly worth 9...The Oxford Club | SponsoredWhy This Small AI Company Holds 150 PatentsJeff Brown, the tech investor who identified Nvidia in 2016 before its 37,000% run, has flagged a new AI compa...Brownstone Research | SponsoredGold majors have a big problemNewmont spent 15 billion dollars acquiring Newcrest in 2023, the largest deal in gold mining history. Yet prod...Golden Portfolio | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredIran War WARNING: Something Just ChangedA powerful Middle Eastern government is reportedly asking Trump for U.S. military help against Iran backed for...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avalon GloboCare Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avalon GloboCare With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
